BioNexus Gene Lab Corp's total assets for Q were $11.14M, a decrease of -0.19% from the previous quarter. BGLC total liabilities were $1.59M for the fiscal quarter, a -12.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.